Literature DB >> 16754543

Attention-deficit/hyperactivity disorder: a plausible mouse model?

Sylvie Granon1, Jean-Pierre Changeux.   

Abstract

UNLABELLED: Attention-deficit/hyperactivity disorder (ADHD) is a multifactorial and heterogeneous disorder, highly prevalent in children and characterized by three main components: inattention, lack of inhibitory control and hyperactivity. Epidemiological evidence reveals that ADHD is associated with nicotine exposure, mostly, with prenatal cigarette smoking. Mice deleted for the beta2-subunit gene of the neuronal nicotinic receptor are proposed as a simple and reliable animal model for ADHD.
CONCLUSION: Nicotinic agonists targeting the alpha4beta2 nicotinic receptors alleviate ADHD symptoms and may possibly contribute to an efficient therapy of ADHD children.

Entities:  

Mesh:

Year:  2006        PMID: 16754543     DOI: 10.1080/08035250600719747

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  18 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors.

Authors:  Sameera M Kassam; Patrick M Herman; Nathalie M Goodfellow; Nyresa C Alves; Evelyn K Lambe
Journal:  J Neurosci       Date:  2008-08-27       Impact factor: 6.167

Review 3.  Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.

Authors:  Antoine Taly; Pierre-Jean Corringer; Denis Guedin; Pierre Lestage; Jean-Pierre Changeux
Journal:  Nat Rev Drug Discov       Date:  2009-09       Impact factor: 84.694

4.  Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggests post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD.

Authors:  Mattis B Wigestrand; Yann S Mineur; Christopher J Heath; Frode Fonnum; Marina R Picciotto; Sven Ivar Walaas
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

5.  The Ferrier Lecture 1998. The molecular biology of consciousness investigated with genetically modified mice.

Authors:  Jean-Pierre Changeux
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

Review 6.  Prefrontal neuromodulation by nicotinic receptors for cognitive processes.

Authors:  Renata dos Santos Coura; Sylvie Granon
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

7.  Nicotinic α5 subunits drive developmental changes in the activation and morphology of prefrontal cortex layer VI neurons.

Authors:  Craig D C Bailey; Nyresa C Alves; Raad Nashmi; Mariella De Biasi; Evelyn K Lambe
Journal:  Biol Psychiatry       Date:  2011-10-25       Impact factor: 13.382

Review 8.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

Review 9.  Nicotinic acetylcholine receptor ligands, a patent review (2006-2011).

Authors:  Daniela Gündisch; Christoph Eibl
Journal:  Expert Opin Ther Pat       Date:  2011-12       Impact factor: 6.674

10.  Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion.

Authors:  Maria Elena Avale; Philippe Faure; Stéphanie Pons; Patricia Robledo; Thierry Deltheil; Denis J David; Alain M Gardier; Rafael Maldonado; Sylvie Granon; Jean-Pierre Changeux; Uwe Maskos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.